AAM Weighs Options On CA Drug Pricing Law; Expert Says Legal Challenge Would Be Difficult

Top pharmaceutical trade groups haven't yet said they will sue over California’s newly signed drug pricing law, but the generics trade group tells Inside Health Policy it is weighing its options. One drug pricing expert who has advocated for similar legislation says the California law is less susceptible to the patent law and Takings Clause challenges faced by other states’ drug-pricing laws, but multiple industry trade groups allege the California law raises trade secret concerns. Governor Jerry Brown...